Stockreport

Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital [Yahoo! Finance]

Opus Genetics, Inc.  (IRD) 
PDF - Strategic financing to accelerate development of earlier-stage gene therapy programs with three additional programs entering clinical testing over the next year - - [Read more]